Galectin-3 in atrial fibrillation: Mechanisms and therapeutic implications

57Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

Maintenance of atrial fibrillation is a complex mechanism, including extensive electrical and structural remodeling of the atria which involves progressive fibrogenesis. Galectin-3 is a biomarker of fibrosis, and, thus, may be involved in atrial remodeling in atrial fibrillation patients. We review the role of galectin-3 in AF mechanisms and its potential therapeutic implications.

Cite

CITATION STYLE

APA

Clementy, N., Piver, E., Bisson, A., Andre, C., Bernard, A., Pierre, B., … Babuty, D. (2018, April 1). Galectin-3 in atrial fibrillation: Mechanisms and therapeutic implications. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms19040976

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free